Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition

Madrigal Licenses Gene Therapy Candidate for MASH Treatment

Citius Oncology Secures $36.5M to Boost LYMPHIR Launch

Astellas Provides Update on Marketing Authorization Application for Avacincaptad Pegol (ACP) in the European Union

Read more

A Timeline of Gene Editing Landmarks

Read more

TreeFrog Therapeutics Enters Into Pioneering Research Collaboration in Immuno-Oncology With the University of Pittsburgh

Read more

European Commission Approves DARZALEX (daratumumab)-SC Quadruplet Regimen for Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma

Read more

Lilly’s Kisunla Gains Marketing Authorization in Great Britain for Alzheimer’s Treatment in Select Adult Patients

Read more

Be Bio Announces $82 Million Financing and Transition to Clinical Stage Company

Read more

Alvotech and Teva Receive FDA Approval for Expanded SELARSDI (ustekinumab-aekn) Presentation, Aligning Indications with Stelara (ustekinumab)

Read more

Ocuphire Pharma Announces Acquisition of Opus Genetics

Read more

FDA Approves Pfizer’s RSV Vaccine ABRYSVO for Adults Aged 18 to 59 at Increased Risk for Disease

Read more

Shaping the Future of Therapeutic Gene Editing

Read more

Posts pagination

Previous Page 1 of 923 … Page 98 of 923 … Page 923 of 923 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version